The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
Open Access
- 13 May 2020
- journal article
- letter
- Published by Elsevier BV in Immunity
- Vol. 52 (6), 887-889
- https://doi.org/10.1016/j.immuni.2020.04.018
Abstract
No abstract availableFunding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
- National Institute of General Medical Sciences
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- American Heart Association
- National Institute on Drug Abuse
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
This publication has 14 references indexed in Scilit:
- Natural Killer Cells in the LungsFrontiers in Immunology, 2019
- Dynamics of Sendai Virus Spread, Clearance, and Immunotherapeutic Efficacy after Hematopoietic Cell Transplant Imaged Noninvasively in MiceJournal of Virology, 2018
- Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69 − CD56 dim cellsJournal of Allergy and Clinical Immunology, 2016
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemiaScience Translational Medicine, 2016
- Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation SyndromeArthritis & Rheumatology, 2015
- Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer ImmunotherapyFrontiers in Immunology, 2013
- Critical Role of Natural Killer Cells in Lung Immunopathology During Influenza Infection in MiceThe Journal of Infectious Diseases, 2012
- Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus InfectionJournal of Virology, 2012
- Interleukin 18 Coexpression during Respiratory Syncytial Virus Infection Results in Enhanced Disease Mediated by Natural Killer CellsJournal of Virology, 2010
- Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumoniaBlood, 2002